Angola vs Malta: Access to anti-retroviral drugs, female
Angola
50.0%
in 2024
Malta
47.0%
in 2024
Angola rank
122nd
Malta rank
124th
Access to anti-retroviral drugs, female over time
- Angola
- Malta
How they compare
Angola currently reports 50.0% against 47.0% in Malta, a difference of 3.0%.
That makes Angola's figure about 1.1 times Malta's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Malta ahead.
Angola ranks 122nd and Malta ranks 124th of 141 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.7% | 24.5% | 22.8% | Malta |
| 2010s | 20.6% | 49.1% | 28.5% | Malta |
| 2020s | 43.0% | 68.4% | 25.4% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Angola or Malta?
- Angola, at 50.0% against 47.0% in Malta as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Angola and Malta?
- 3.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Malta?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and Malta rank globally for access to anti-retroviral drugs, female?
- Angola ranks 122nd and Malta ranks 124th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.